Cargando…

Immunotherapy: A new target for cancer cure (Review)

Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, show...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Fuqian, Shen, Daofu, Shang, Mingquan, Yu, Hao, Zuo, Xiaoxue, Chen, Lixin, Huang, Zhijin, Li, Lianxing, Wang, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091078/
https://www.ncbi.nlm.nih.gov/pubmed/36999633
http://dx.doi.org/10.3892/or.2023.8537
_version_ 1785023081931079680
author Zhao, Fuqian
Shen, Daofu
Shang, Mingquan
Yu, Hao
Zuo, Xiaoxue
Chen, Lixin
Huang, Zhijin
Li, Lianxing
Wang, Lei
author_facet Zhao, Fuqian
Shen, Daofu
Shang, Mingquan
Yu, Hao
Zuo, Xiaoxue
Chen, Lixin
Huang, Zhijin
Li, Lianxing
Wang, Lei
author_sort Zhao, Fuqian
collection PubMed
description Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, showing potential for cancer therapy. The present review discusses the role of the immune system in the treatment of tumor. The strategies for treating tumors are briefly introduced from aspects of active immunization and passive immunotherapy and the dendritic cell vaccines and oncolytic viruses are highlighted, as well as use of blood group A antigen in the treatment of solid tumors.
format Online
Article
Text
id pubmed-10091078
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-100910782023-04-13 Immunotherapy: A new target for cancer cure (Review) Zhao, Fuqian Shen, Daofu Shang, Mingquan Yu, Hao Zuo, Xiaoxue Chen, Lixin Huang, Zhijin Li, Lianxing Wang, Lei Oncol Rep Review Cancer is the leading cause of death globally and there is a worldwide cancer epidemic. Immunotherapy has emerged as a promising anticancer therapy. In particular, oncolytic viruses destroy cancer cells without destroying normal tissue via viral self-replication and anti-tumor immune responses, showing potential for cancer therapy. The present review discusses the role of the immune system in the treatment of tumor. The strategies for treating tumors are briefly introduced from aspects of active immunization and passive immunotherapy and the dendritic cell vaccines and oncolytic viruses are highlighted, as well as use of blood group A antigen in the treatment of solid tumors. D.A. Spandidos 2023-03-28 /pmc/articles/PMC10091078/ /pubmed/36999633 http://dx.doi.org/10.3892/or.2023.8537 Text en Copyright: © Zhao et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Review
Zhao, Fuqian
Shen, Daofu
Shang, Mingquan
Yu, Hao
Zuo, Xiaoxue
Chen, Lixin
Huang, Zhijin
Li, Lianxing
Wang, Lei
Immunotherapy: A new target for cancer cure (Review)
title Immunotherapy: A new target for cancer cure (Review)
title_full Immunotherapy: A new target for cancer cure (Review)
title_fullStr Immunotherapy: A new target for cancer cure (Review)
title_full_unstemmed Immunotherapy: A new target for cancer cure (Review)
title_short Immunotherapy: A new target for cancer cure (Review)
title_sort immunotherapy: a new target for cancer cure (review)
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091078/
https://www.ncbi.nlm.nih.gov/pubmed/36999633
http://dx.doi.org/10.3892/or.2023.8537
work_keys_str_mv AT zhaofuqian immunotherapyanewtargetforcancercurereview
AT shendaofu immunotherapyanewtargetforcancercurereview
AT shangmingquan immunotherapyanewtargetforcancercurereview
AT yuhao immunotherapyanewtargetforcancercurereview
AT zuoxiaoxue immunotherapyanewtargetforcancercurereview
AT chenlixin immunotherapyanewtargetforcancercurereview
AT huangzhijin immunotherapyanewtargetforcancercurereview
AT lilianxing immunotherapyanewtargetforcancercurereview
AT wanglei immunotherapyanewtargetforcancercurereview